Clinical Trial Update: Once Weekly GLP-1 in Persons With Spinal Cord Injury [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating once-weekly GLP-1 in individuals with spinal cord injury, focusing on insulin resistance and related metabolic conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Obesity
• Pre-diabetes
• Spinal Cord Injuries

Drugs mentioned

• GLP-1 (glucagon-like peptide-1)

Snippet

Sponsor: James J. Peters Veterans Affairs Medical Center | Conditions: Spinal Cord Injuries, Insulin Resistance | Phase 4 | Status: COMPLETED